Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Apatinib|DRUG: Oral Vinorelbine
Sponsor: Chinese Academy of Medical Sciences